Skip to main content
. 2017 Aug 10;56(17):2335–2338. doi: 10.2169/internalmedicine.8706-16

Table 2.

Summary of the Philadelphia-negative MPN Cases in which TLS Developed.

Reference Age Sex Diagnosis Spleen size Cause of TLS Treatment for TLS Outcome
12 63 M blastic phase PV spleen enlarged spontaneously hydration, allopurinol died within 2 days
13 81 M blastic phase PV massive splenomegaly 14 days after administration of HU hemodialysis recovered
14 66 F post PV myelofibrosis massive splenomegaly splenic irradiation hydration, allopurinol recovered
15 70 M MF marked splenomegaly spontaneously hemodialysis recovered
16 47 M PMF extreme splenomegaly spontanesouly, hydronephrosis due to stones in bilateral ureteral stones bilateral ureteral stent, hydration, allopurinol recovered
17 70 F post PV myelofibrosis massive splenomegaly ruxolitinib withdrawal hydration, sodium polystyrene sulfonate, intravenous insulin and glucose, rasburicase recovered
This case 62 F post PV myelofibrosis massibe splenomegaly ruxolitinib admisistration hydration, sodium polystyrene sulfonate, intravenous insulin and glucose, allopurinol recovered

PV: polycythemia vera, PMF: primary myelofibrosis, HU: Hydroxyurea